×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Improving Communication Across Differences in Drug Development Teams
Session Chair(s)
Jennifer Kim, PhD
Research Assistant Professor
Tufts Center for the Study of Drug Development, United States
The interactive workshop will provide an opportunity for participants to discuss common barriers that hinder effective communication in cross-cultural, diverse teams. Discussion will draw from the management, psychology, and drug development literature to help contextualize communication and feedback giving.
Learning Objective : Identify and discuss common interactions and patterns that can hinder effective communication in diverse and cross-cultural teams in drug development; Describe common pitfalls and fallacies related to feedback and learn how to avoid them; Identify evidence-based solutions on how to reduce barriers to communication.
Speaker(s)
Empirical Perspective: What the Research on Team Communication in Drug Development Reveals
Emily Botto, MPH
Tufts Center for the Study of Drug Development, United States
Senior Research Analyst
Learning and Development Perspective: Best Practices for Training and Implementation
Tamei Elliott, MS
DIA, United States
Associate Director, Scientific Programs
Case Perspective: Learnings from the Field
Christine Mayer-Nicolai, PharmD
Merck Healthcare KGaA, Germany
Vice President, Regulatory and Scientific Policy
Have an account?